全文获取类型
收费全文 | 24628篇 |
免费 | 2730篇 |
国内免费 | 551篇 |
专业分类
耳鼻咽喉 | 181篇 |
儿科学 | 413篇 |
妇产科学 | 400篇 |
基础医学 | 1704篇 |
口腔科学 | 1294篇 |
临床医学 | 5611篇 |
内科学 | 3664篇 |
皮肤病学 | 338篇 |
神经病学 | 1266篇 |
特种医学 | 251篇 |
外国民族医学 | 1篇 |
外科学 | 2195篇 |
综合类 | 1800篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 2616篇 |
眼科学 | 297篇 |
药学 | 2477篇 |
17篇 | |
中国医学 | 1825篇 |
肿瘤学 | 1554篇 |
出版年
2024年 | 142篇 |
2023年 | 1001篇 |
2022年 | 1539篇 |
2021年 | 2100篇 |
2020年 | 1989篇 |
2019年 | 1630篇 |
2018年 | 1405篇 |
2017年 | 1243篇 |
2016年 | 1257篇 |
2015年 | 1038篇 |
2014年 | 2013篇 |
2013年 | 2036篇 |
2012年 | 1312篇 |
2011年 | 1466篇 |
2010年 | 1119篇 |
2009年 | 999篇 |
2008年 | 1032篇 |
2007年 | 857篇 |
2006年 | 807篇 |
2005年 | 657篇 |
2004年 | 482篇 |
2003年 | 422篇 |
2002年 | 277篇 |
2001年 | 230篇 |
2000年 | 154篇 |
1999年 | 106篇 |
1998年 | 80篇 |
1997年 | 72篇 |
1996年 | 74篇 |
1995年 | 54篇 |
1994年 | 48篇 |
1993年 | 31篇 |
1992年 | 28篇 |
1991年 | 30篇 |
1990年 | 16篇 |
1989年 | 24篇 |
1988年 | 26篇 |
1987年 | 12篇 |
1986年 | 16篇 |
1985年 | 13篇 |
1984年 | 10篇 |
1983年 | 15篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1976年 | 8篇 |
1975年 | 9篇 |
1969年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Ignacio Aguirre-Allende Jose Maria Enriquez-Navascues Garazi Elorza-Echaniz Ane Etxart-Lopetegui Nerea Borda-Arrizabalaga Yolanda Saralegui Ansorena Carlos Placer-Galan 《Cirugía espa?ola》2021,99(2):89-107
Local excision (LE) has arisen as an alternative to total mesorectal excision for the treatment of early rectal cancer. Despite a decreased morbidity, there are still concerns about LE outcomes.This systematic-review and meta-analysis design is based on the “PICO” process, aiming to answer to three questions related to LE as primary treatment for early-rectal cancer, the optimal method for LE, and the potential role for completion treatment in high-risk histology tumors and outcomes of salvage surgery.The results revealed that reported overall survival (OS) and disease-specific survival (DSS) were 71%–91.7% and 80%–94% for LE, in contrast to 92.3%–94.3% and 94.4%–97% for radical surgery. Additional analysis of National Database studies revealed lower OS with LE (HR: 1.26; 95%CI, 1.09–1.45) and DSS (HR: 1.19; 95%CI, 1.01–1.41) after LE. Furthermore, patients receiving LE were significantly more prone develop local recurrence (RR: 3.44, 95%CI, 2.50–4.74). Analysis of available transanal surgical platforms was performed, finding no significant differences among them but reduced local recurrence compared to traditional transanal LE (OR:0.24;95%CI, 0.15–0.4). Finally, we found poor survival outcomes for patients undergoing salvage surgery, favoring completion treatment (chemoradiotherapy or surgery) when high-risk histology is present.In conclusion, LE could be considered adequate provided a full-thickness specimen can be achieved that the patient is informed about risk for potential requirement of completion treatment. Early-rectal cancer cases should be discussed in a multidisciplinary team, and patient's preferences must be considered in the decision-making process. 相似文献
83.
84.
Qing-song Xie Zi-xiang Chen Yi-jun Zhao Heng Gu Xiao-ping Geng Fu-bao Liu 《Asian journal of surgery / Asian Surgical Association》2021,44(1):36-45
Long-term overall survival (OS) after liver resection for non-cirrhotic hepatocellular carcinoma (NCHCC) has been reported recently. The aim of this study was to review outcomes systematically and analyze risk factors for survival after surgical resection for HCC without cirrhosis. A literature search was performed of the PubMed and Embase databases for papers published between January 1995 and October 2012, which focused on hepatic resection for HCC without underlying cirrhosis. Cochrane systematic review methodology was used for this review. Outcomes were OS, operative mortality and disease-free survival (DFS). Pooled hazard ratios (HR) were calculated using the random effects model for parameters considered as potential prognostic factors. Totally, 26 retrospective case series were eligible for inclusion. The 1-, 3- and 5-year OS rate after surgical resection of NCHCC ranged from 62% to 100%, 46.3%–78.0%, and 30%–64%, respectively. The corresponding DFS rates ranged from 48.7% to 84%, 31.0%–66.0%, and 24.0%–58.0%, respectively. Five variables were related to poor survival: multiple tumors (HR 1.68, 95%CI 1.25–2.11); larger tumor size (HR 2.66, 95%CI 1.69–3.63); non-clear resection margin (R0 resection) (HR 3.52, 95%CI 1.63–5.42); poor tumor stage (HR 2.61, 95%CI 1.64–3.58); and invasion of the lymphatic vessels (HR 4.85, 95%CI 2.67–7.02). In sum, hepatic resection provides excellent OS rates for patients with NCHCC, and results have tended to improve recently. Risk factors for poor prognosis comprise multiple tumors, lager tumor size, non-R0 resection and invasion of the lymphatic vessels. 相似文献
85.
86.
87.
88.
Jian Zhang Qingyuan Liang Dean Qin Jiefu Song Qijun An Xiaojian Wang Zhongtao Zhao 《The journal of spinal cord medicine》2021,44(3):340
Study Design: Systematic review and meta-analysis.Objective: To compare the effectiveness and safety between anterior and posterior approach, and determine the best surgical methods for the treatment of ossification of the posterior longitudinal ligament (OPLL) in the cervical spine.Methods: We searched the Cochrane Library, PubMed, CNKI and Wanfang Med Data databases from January 2007 to March 2018. Japanese Orthopaedic Association (JOA) scores, cervical lordosis, functional recovery rates, excellent and good outcomes of the surgical approaches, and complication and reoperation rates were analyzed. RevMan 5.3 was utilized for data analysis.Results: Eleven studies were included in the meta-analysis. By comparing the anterior and posterior approaches for the treatment of OPLL in the cervical spine, statistically significant differences were found in the preoperative initial JOA, the postoperative final JOA scores, functional recovery rates, complication rates, excellent and good outcomes of the surgical approaches and reoperation rates. However, no statistically significant difference in the occurrence of the preoperative and postoperative cervical lordosis was noted.Conclusion: The anterior approach is superior to the posterior approach in terms of the postoperative final JOA score, functional recovery rate, and clinical outcomes. Although the complication and reoperation rates of the anterior approach are higher than those of the posterior approach. We recommend the anterior approach for the treatment of OPLL when patients with occupying ratio ≥ 60%. In addition, high-quality studies with long-term follow-up and large sample size are also needed. 相似文献
89.
90.
目的通过系统评价和Meta分析探讨阿帕替尼与替吉奥对比治疗结肠癌的有效性和安全性。方法以"阿帕替尼""替吉奥""结肠癌""等为中文关键词,以"Apatinib""Tegafur""Colon cancer"等为英文关键词,检索PubMed,Cochrane Library,Embase,Web of Science,中国知网、中国生物医学文献服务系统、维普数据库、万方数据知识服务平台,时间限制在从建库到2020年12月。评价阿帕替尼和替吉奥对结肠癌的总体疗效,结肠癌进展和无进展生存期的差异。研究采用RevMan 5.3软件进行Meta分析。结果Meta分析结果显示,阿帕替尼与替吉奥对结肠癌的疗效相比,部分缓解+稳定的差异没有统计学意义(RR=1.10,95%CI,0.71~1.71,P=0.640),在结肠癌进展方面的差异没有统计学意义(RR=0.51,95%CI:0.28~1.32,P=0.205),在无进展生存期方面阿帕替尼组大于替吉奥组,差异具有统计学意义(SMD=0.90,95%CI;0.42~1.37,P<0.0001)。结论相较于替吉奥,阿帕替尼用于治疗结肠癌患者能明显延长无进展生存期,总体生存效益有所提高。 相似文献